VYNE Therapeutics Inc. (VYNE) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 25.79M | 30.01M | 35.89M | 44.34M | 54.91M | 64.44M | 73.53M | 83.78M | 90.22M | 95.96M | 17.51M | 22.96M | 33.02M | 38.27M | 44.05M | 51.92M | 60.65M | 63.19M | 76.13M | 128.43M |
| Cash & Short-Term Investments | 24.93M | 29.01M | 32.7M | 39.65M | 50.27M | 61.52M | 70.19M | 78.1M | 86M | 93.25M | 15.45M | 20.63M | 30.21M | 30.91M | 35.51M | 42.81M | 50.49M | 42.25M | 52.31M | 103.41M |
| Cash Only | 24.63M | 24.03M | 19.35M | 22.05M | 28.21M | 19.93M | 16.27M | 29.61M | 19.12M | 30.62M | 15.45M | 20.63M | 30.21M | 30.91M | 35.51M | 42.81M | 50.49M | 42.25M | 52.31M | 103.41M |
| Short-Term Investments | 297K | 4.98M | 13.35M | 17.6M | 22.06M | 41.59M | 53.91M | 48.49M | 66.89M | 62.63M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 250K | 234K | 105K | 5M | 5.47M | 5.3M | 5.54M | 7.58M | 10.08M | 10.87M |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | 195.3 | 114.26 | 2.32K | 80.28K | 2.97K | 3.91K | 3.32K | 354.57 | 7.25K | 3.34K |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 54K | 67K | 0 | 0 | 0 | 0 | 0 | 7.29M | 8.07M | 8.28M |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 782.51 | 26.86K | 26.6K |
| Other Current Assets | 861K | 1M | 3.19M | 4.7M | 4.64M | 2.92M | 3.35M | 5.67M | 4.22M | 2.71M | 1.76M | 2.02M | 67K | 240K | 67K | 30K | 729K | 1.5M | 605K | 605K |
| Total Non-Current Assets | 84K | 150K | 246K | 375K | 1.51M | 2.47M | 2.66M | 2.87M | 1.45M | 1.72M | 1.76M | 2M | 2.24M | 2.48M | 2.86M | 3.27M | 3.67M | 3.86M | 5.19M | 5.56M |
| Property, Plant & Equipment | 84K | 90K | 96K | 134K | 169K | 206K | 122K | 151K | 180K | 207K | 0 | 0 | 0 | 0 | 127K | 298K | 310K | 354K | 1.51M | 1.73M |
| Fixed Asset Turnover | 0.99x | 1.40x | 1.47x | 0.46x | 1.08x | 0.51x | 0.89x | 1.20x | 0.51x | 0.37x | - | - | - | - | 0.79x | 0.41x | 0.54x | 2.46x | 0.08x | 0.16x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 60K | 150K | 241K | 1.34M | 2.26M | 2.54M | 2.72M | 1.27M | 1.51M | 1.76M | 2M | 2.24M | 2.48M | 2.73M | 2.97M | 3.35M | 3.51M | 3.68M | 3.83M |
| Total Assets | 25.87M | 30.16M | 36.13M | 44.72M | 56.42M | 66.91M | 76.2M | 86.65M | 91.68M | 97.69M | 19.27M | 24.96M | 35.26M | 40.76M | 46.91M | 55.19M | 64.32M | 67.05M | 81.31M | 133.98M |
| Asset Turnover | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.03x | 0.00x | 0.00x |
| Asset Growth % | -54.14% | -54.92% | -52.58% | -48.39% | -38.45% | -31.51% | 295.48% | 247.16% | 159.98% | 139.67% | -58.93% | -54.78% | -45.17% | -39.21% | -42.31% | -58.81% | -56.88% | -28.48% | -24.49% | 2.4% |
| Total Current Liabilities | 1.24M | 2.4M | 4.04M | 5.84M | 12.29M | 14.82M | 12.66M | 11.75M | 6.93M | 7.54M | 6.45M | 6.37M | 7.52M | 9.35M | 6.84M | 6.83M | 8.59M | 18.41M | 21M | 57.62M |
| Accounts Payable | 261K | 1.04M | 1.2M | 1.41M | 3.53M | 2.71M | 3.99M | 4.52M | 2.79M | 1.66M | 716K | 1.16M | 2.21M | 2.39M | 2.52M | 1.43M | 3.61M | 6.51M | 7.62M | 10.08M |
| Days Payables Outstanding | 9.76K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 719.85 | 29.08K | 22.05K |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33.38M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 975K | 1.35M | 1.71M | 819K | 1.84M | 2.74M | 8.55M | 2.05M | 3.64M | 1.65M | 4.45M | 4.38M | 4.39M | 2.58M | 2.15M | 1.86M | 1.55M | 2.96M | 3.49M | 3.58M |
| Current Ratio | 20.86x | 12.53x | 8.87x | 7.60x | 4.47x | 4.35x | 5.81x | 7.13x | 13.02x | 12.73x | 2.72x | 3.60x | 4.39x | 4.10x | 6.44x | 7.60x | 7.06x | 3.43x | 3.63x | 2.23x |
| Quick Ratio | 20.86x | 12.53x | 8.87x | 7.60x | 4.47x | 4.35x | 5.81x | 7.13x | 13.02x | 12.73x | 2.71x | 3.59x | 4.39x | 4.10x | 6.44x | 7.60x | 7.06x | 3.04x | 3.24x | 2.09x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 417.23 | 5.03K | 7.89K |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25K | 1.38M | 1.41M | 1.31M | 1.31M | 1.31M | 211K | 0 | 0 | 0 | 0 | 1.43M | 1.47M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25K | 63K | 99K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 775K | 812K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.31M | 1.31M | 1.31M | 1.31M | 1.31M | 211K | 0 | 0 | 0 | 0 | 657K | 658K |
| Total Liabilities | 1.24M | 2.4M | 4.04M | 5.84M | 12.29M | 14.82M | 12.66M | 11.78M | 8.31M | 8.95M | 7.76M | 7.69M | 8.83M | 9.56M | 6.84M | 6.83M | 8.59M | 18.41M | 22.43M | 59.09M |
| Total Debt | 0 | 0 | 0 | 25K | 63K | 99K | 123K | 145K | 180K | 214K | 0 | 0 | 0 | 0 | 0 | 31K | 117K | 349K | 1.05M | 34.62M |
| Net Debt | -24.63M | -24.03M | -19.35M | -22.02M | -28.15M | -19.83M | -16.15M | -29.46M | -18.94M | -30.41M | -15.45M | -20.63M | -30.21M | -30.91M | -35.51M | -42.78M | -50.38M | -41.9M | -51.25M | -68.78M |
| Debt / Equity | - | - | - | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | - | - | - | - | - | 0.00x | 0.00x | 0.01x | 0.02x | 0.46x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.03x | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -3.47x | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -3.11x | -8.95x |
| Total Equity | 24.64M | 27.77M | 32.09M | 38.88M | 44.13M | 52.09M | 63.54M | 74.87M | 83.37M | 88.73M | 11.51M | 17.27M | 26.43M | 31.2M | 40.07M | 48.36M | 55.73M | 48.64M | 58.89M | 74.89M |
| Equity Growth % | -44.17% | -46.69% | -49.5% | -48.07% | -47.06% | -41.3% | 452.26% | 333.47% | 215.43% | 184.39% | -71.29% | -64.28% | -52.57% | -35.85% | -31.95% | -35.43% | -40.01% | 29.72% | 18.92% | 4.7% |
| Book Value per Share | 0.58 | 0.65 | 0.75 | 0.91 | 1.03 | 1.22 | 1.49 | 1.76 | 1.96 | 2.86 | 3.51 | 5.28 | 8.11 | 10.45 | 12.45 | 15.03 | 18.11 | 16.36 | 20.37 | 26.22 |
| Total Shareholders' Equity | 24.64M | 27.77M | 32.09M | 38.88M | 44.13M | 52.09M | 63.54M | 74.87M | 83.37M | 88.73M | 11.51M | 17.27M | 26.43M | 31.2M | 40.07M | 48.36M | 55.73M | 48.64M | 58.89M | 74.89M |
| Common Stock | 3K | 3K | 3K | 2K | 2K | 1K | 1K | 1K | 1K | 1K | 0 | 0 | 0 | 0 | 6K | 6K | 6K | 5K | 5K | 5K |
| Retained Earnings | -761.24M | -757.65M | -752.82M | -745.54M | -739.78M | -731.17M | -719.15M | -706.99M | -697.59M | -691.34M | -685.15M | -678.56M | -668.51M | -662.74M | -652.79M | -643.33M | -634.86M | -639.52M | -627.96M | -606.67M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 2K | 4K | -2K | 0 | 20K | 34K | -58K | -70K | 26K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |